Physician profile
Robert Rodriguez
NPI 1366023574
$572.75
in general payments reported to CMS, 2019-2025
9 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $26.24 · 2024: $375 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $298.44 | 2024-2025 | Embotrap, Cerebase, N/A |
| Astrazeneca Pharmaceuticals LP | $66.73 | 2024-2025 | Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $64.93 | 2024-2025 | |
| Corcept Therapeutics | $46.69 | 2024 | Korlym |
| Qapel Medical INC | $26.24 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $22.42 | 2024 | Zoryve |
| Novo Nordisk INC | $17.78 | 2024 | Wegovy |
| Lilly USA, LLC | $14.89 | 2024 | Mounjaro |
| Pfizer INC. | $14.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.